Literature DB >> 26108224

Site-1 protease-activated formation of lysosomal targeting motifs is independent of the lipogenic transcription control.

Sarah Klünder1, Jörg Heeren2, Sandra Markmann1, René Santer1, Thomas Braulke1, Sandra Pohl1.   

Abstract

Site-1 protease (S1P) cleaves membrane-bound lipogenic sterol regulatory element-binding proteins (SREBPs) and the α/β-subunit precursor protein of the N-acetylglucosamine-1-phosphotransferase forming mannose 6-phosphate (M6P) targeting markers on lysosomal enzymes. The translocation of SREBPs from the endoplasmic reticulum (ER) to the Golgi-resident S1P depends on the intracellular sterol content, but it is unknown whether the ER exit of the α/β-subunit precursor is regulated. Here, we investigated the effect of cholesterol depletion (atorvastatin treatment) and elevation (LDL overload) on ER-Golgi transport, S1P-mediated cleavage of the α/β-subunit precursor, and the subsequent targeting of lysosomal enzymes along the biosynthetic and endocytic pathway to lysosomes. The data showed that the proteolytic cleavage of the α/β-subunit precursor into mature and enzymatically active subunits does not depend on the cholesterol content. In either treatment, lysosomal enzymes are normally decorated with M6P residues, allowing the proper sorting to lysosomes. In addition, we found that, in fibroblasts of mucolipidosis type II mice and Niemann-Pick type C patients characterized by aberrant cholesterol accumulation, the proteolytic cleavage of the α/β-subunit precursor was not impaired. We conclude that S1P substrate-dependent regulatory mechanisms for lipid synthesis and biogenesis of lysosomes are different.
Copyright © 2015 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Golgi apparatus; LDL receptor; Niemann-Pick type C1 disease; cholesterol; endocytosis; lysosome; mannose 6-phosphate; mucolipidosis type II; statins

Mesh:

Substances:

Year:  2015        PMID: 26108224      PMCID: PMC4514003          DOI: 10.1194/jlr.M060756

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  35 in total

Review 1.  The SREBP pathway--insights from Insigs and insects.

Authors:  Robert B Rawson
Journal:  Nat Rev Mol Cell Biol       Date:  2003-08       Impact factor: 94.444

2.  Extracellular release as the major degradative pathway of the insulin-like growth factor II/mannose 6-phosphate receptor.

Authors:  K B Clairmont; M P Czech
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

3.  Regulation of soluble insulin-like growth factor-II/mannose 6-phosphate receptor in hepatocytes from intact and regenerating rat liver.

Authors:  C D Scott; R C Baxter
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

Review 4.  The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

Authors:  M S Brown; J L Goldstein
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

5.  Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies.

Authors:  J Sakai; A Nohturfft; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

6.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells.

Authors:  J L Goldstein; S K Basu; M S Brown
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER.

Authors:  Tong Yang; Peter J Espenshade; Michael E Wright; Daisuke Yabe; Yi Gong; Ruedi Aebersold; Joseph L Goldstein; Michael S Brown
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

8.  Biosynthesis and maturation of arylsulfatase B in normal and mutant cultured human fibroblasts.

Authors:  F Steckel; A Hasilik; K von Figura
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

9.  Impaired cholesterol esterification in cultured skin fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy.

Authors:  K Inui; J Nishimoto; S Okada; H Yabuuchi
Journal:  Biochem Int       Date:  1989-06

10.  Is movement of mannose 6-phosphate-specific receptor triggered by binding of lysosomal enzymes?

Authors:  T Braulke; C Gartung; A Hasilik; K von Figura
Journal:  J Cell Biol       Date:  1987-06       Impact factor: 10.539

View more
  2 in total

1.  Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents.

Authors:  Anastasia Hyrina; Fanrui Meng; Steven J McArthur; Sharlene Eivemark; Ivan R Nabi; François Jean
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

Review 2.  The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol.

Authors:  Nabil G Seidah
Journal:  Glob Cardiol Sci Pract       Date:  2017-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.